Ocular Therapeutix

/Ocular Therapeutix

Secondary

Ocular Therapeutix

They are a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology.

Symbol

OCUL

Last Closing Price
$6.19

Shares
4,800,000

Effective Date
January 25, 2018

Underwriters
Piper Jaffray

To view the prospectus for Ocular Therapeutix, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277